TY - JOUR
T1 - Functional causal mediation analysis with an application to brain connectivity
AU - Lindquist, Martin A.
N1 - Funding Information:
Martin A. Lindquist is Associate Professor, Department of Statistics, Columbia University, New York, NY 10027 (E-mail: martin@stat.columbia.edu). The author thanks Michael Sobel for all his help with the preparation of this article, Niall Bolger for helpful comments, and Tor Wager for supplying the data. This work was partially funded by the National Institute on Drug Abuse (NIDA) grant 1RC1DA028608.
PY - 2012
Y1 - 2012
N2 - Mediation analysis is often used in the behavioral sciences to investigate the role of intermediate variables that lie on the causal path between a randomized treatment and an outcome variable. Typically, mediation is assessed using structural equation models (SEMs), with model coefficients interpreted as causal effects. In this article, we present an extension of SEMs to the functional data analysis (FDA) setting that allows the mediating variable to be a continuous function rather than a single scalar measure, thus providing the opportunity to study the functional effects of the mediator on the outcome. We provide sufficient conditions for identifying the average causal effects of the functional mediators using the extended SEM, as well as weaker conditions under which an instrumental variable estimand may be interpreted as an effect. The method is applied to data from a functional magnetic resonance imaging (fMRI) study of thermal pain that sought to determine whether activation in certain brain regions mediated the effect of applied temperature on self-reported pain. Our approach provides valuable information about the timing of the mediating effect that is not readily available when using the standard nonfunctional approach. To the best of our knowledge, this work provides the first application of causal inference to the FDA framework.
AB - Mediation analysis is often used in the behavioral sciences to investigate the role of intermediate variables that lie on the causal path between a randomized treatment and an outcome variable. Typically, mediation is assessed using structural equation models (SEMs), with model coefficients interpreted as causal effects. In this article, we present an extension of SEMs to the functional data analysis (FDA) setting that allows the mediating variable to be a continuous function rather than a single scalar measure, thus providing the opportunity to study the functional effects of the mediator on the outcome. We provide sufficient conditions for identifying the average causal effects of the functional mediators using the extended SEM, as well as weaker conditions under which an instrumental variable estimand may be interpreted as an effect. The method is applied to data from a functional magnetic resonance imaging (fMRI) study of thermal pain that sought to determine whether activation in certain brain regions mediated the effect of applied temperature on self-reported pain. Our approach provides valuable information about the timing of the mediating effect that is not readily available when using the standard nonfunctional approach. To the best of our knowledge, this work provides the first application of causal inference to the FDA framework.
KW - Brain connectivity
KW - Causalinference
KW - FMRI
KW - Functional data analysis
KW - Instrumental variable
KW - Mediation
KW - Structural equation models
UR - http://www.scopus.com/inward/record.url?scp=84871997442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871997442&partnerID=8YFLogxK
U2 - 10.1080/01621459.2012.695640
DO - 10.1080/01621459.2012.695640
M3 - Article
C2 - 25076802
AN - SCOPUS:84871997442
SN - 0162-1459
VL - 107
SP - 1297
EP - 1309
JO - Journal of the American Statistical Association
JF - Journal of the American Statistical Association
IS - 500
ER -